Ensign Peak Advisors
TYRA icon

Ensign Peak Advisors’s Tyra Biosciences TYRA Stock Holding History

Ensign Peak Advisors’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.84M Buy
+74,064
New +$2.4M 0.01% 646
2024
Q4 		– Sell
-115,616
Closed -$2.72M – 1727
2024
Q3 		$2.72M Sell
115,616
-74,941
-39% -$1.57M ﹤0.01% 823
2024
Q2 		$3.05M Buy
+190,557
New +$3.28M 0.01% 767
2022
Q2 		– Sell
-125,000
Closed -$1.34M – 2203
2022
Q1 		$1.34M Hold
125,000
– – ﹤0.01% 1049
2021
Q4 		$1.76M Hold
125,000
– – ﹤0.01% 1013
2021
Q3 		$2.2M Buy
+125,000
New +$2.39M ﹤0.01% 1066

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APMC
Alta Partners Management Company Jackson, Wyoming $151M AUM 296.21% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Ensign Peak Advisors's TYRA Position: Q1 2026 in Review

Ensign Peak Advisors opened a new position in Tyra Biosciences (TYRA) in Q1 2026: 74,064 shares worth $2.84M. The stake represents 0.01% of the portfolio and ranks #646 among its holdings. This is a return to the name: Ensign Peak Advisors previously reported a position in TYRA as recently as Q3 2024.

Ensign Peak Advisors first reported a position in TYRA in Q3 2021 and has held it in 6 quarters since. The position peaked at $3.05M in Q2 2024. 164 funds tracked by Wall St. Rank hold TYRA as of Q1 2026.

  • Ensign Peak Advisors held 74,064 shares of Tyra Biosciences worth $2.84M as of Q1 2026.
  • Tyra Biosciences was a new Ensign Peak Advisors position in Q1 2026.
  • Tyra Biosciences made up 0.01% of Ensign Peak Advisors's portfolio in Q1 2026, its #646 holding.
  • Ensign Peak Advisors first reported a position in Tyra Biosciences in Q3 2021 and has held it in 6 quarters since.
  • Ensign Peak Advisors's Tyra Biosciences position peaked at $3.05M in Q2 2024.
  • 164 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2026.

Based on Ensign Peak Advisors's 13F filing for Q1 2026, filed 13 May 2026.